Abstract 56P
Background
The incidence of colorectal cancer (CRC) has increased among the younger population. Adolescents and young adults (AYA) are an important component of the active population in any country that impact the health care system along with socio-economic consequences. We present one of the first multicentre collaborative studies on AYA CRC from a low and middle-income country (LMIC).
Methods
The study was a multicentre retrospective registry conducted over the period of 3 years, from January 2018 to December 2020, after approval from respective IECs. A total of 126 AYA CRC Patients were enrolled in the study. The details regarding socio-demographic profile, histopathology, and therapeutic details were recorded.
Results
A total of 126 patients of AYA colorectal cancer patients were enrolled in the study between 2018 - 2020. 62.70% of patients had colon cancer, 37.30 % had rectal cancer. 50.79 % of patients were male. 67.46% of patients belong to 31-40 age group, with an average age of 32.6 years. Abdomen pain and distension (34%), and blood in stools (22%) were the most common presentations. On presentation, 31.75% had cTNM stage IV, 28.57% stage III, 15.87% stage II as per AJCC 8. 92(74.60%) underwent surgery, and adenocarcinoma (65.08 %) was the most common histology. 28.57% of patients were stage III on pTNM. Most of the patients were offered potentially curative therapy (65.87%), and 33.33% of patients were on palliative treatment. CAPOX was the most commonly prescribed chemotherapy regimen. MSI profiling was available only for eight patients.
Conclusions
As per our knowledge, this study is one of the first multicentre collaborative studies from an LMIC related to the clinic-pathological profile of AYA CRC patients. Most such patients present in non-metastatic stage, and potentially receive curative therapy. However, only a small minority could get MSI/mutational profiling.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Biotechnology Industry Research Assistance Council (BIRAC) India.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
58P - Clinicopathologic profile and outcomes of rectal cancer (RC) in the young (<50 years old): A single institution experience
Presenter: Fatma Amina Hussin Ibrahim
Session: Poster viewing 02
59P - Platelet-derived growth factor (PDGF)-CC serum as clinical outcome predictor after six cycles of chemotherapy in colorectal cancer at RSMH Palembang
Presenter: Erty Sundarita
Session: Poster viewing 02
60P - Predictors of survival in stage III colorectal cancer patients treated with surgery and adjuvant chemotherapy: A single institution observational study
Presenter: Keng Man Chiang
Session: Poster viewing 02
61P - Can total neoadjuvant therapy in locally advanced rectal cancer replace standard treatment protocol?
Presenter: Ankita Mallick
Session: Poster viewing 02
62P - Chief complaints and baseline clinicopathological features of patients with colorectal cancer in a tertiary hospital in Yogyakarta Indonesia
Presenter: Yasjudan Putra
Session: Poster viewing 02
63P - Tumor sidedness and clinicopathological features of colorectal cancer in Medical Oncology Department, Yangon General Hospital: A retrospective review
Presenter: Thiri Tun
Session: Poster viewing 02
64P - Clinical profile and treatment outcome of patients with non-metastatic colon cancer: A single institutional study from India
Presenter: Sandip Ganguly
Session: Poster viewing 02
65P - Comparison of survival and recurrence pattern in Thai early stage colorectal cancer patients by tumor sidedness
Presenter: Chanchai Charonpongsuntorn
Session: Poster viewing 02
77P - Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer: The FUGES-012 randomized clinical trial
Presenter: Qing Zhong
Session: Poster viewing 02